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For the coxarthrosis stage, we employed the classiﬁcation by the
Japanese Orthopaedic Association’s committee. It deﬁned ﬁve groups:
almost normal, prearthrosis, the initial stage, the advanced stage, and
the terminal stage. The committee focused on three roentgenographic
features, namely the width of the joint space, the structure of bony
architecture, and the shape of the acetabular roof and the femoral head.
One of the authors, whose institution did not participate in ﬁlm read-
ing, performed the statistical analysis. On the coxarthrosis stage, he
computed the value of the kappa statistics and evaluated the strength
of observer agreement. On the roentgenographic indexes, he set up a
mixed linear model to calculate the coefﬁcient of variation. Based on this
premise, he calculated the coefﬁcient of variation using the analysis of
variance (ANOVA).
Study 2: To overcome the difﬁculty in staging coxarthrosis, we deﬁned
the description of stages from our own point of view and selected
typical radiographs for reference. The same 12 authors assessed the
roentgenographic stage on the same radiographs again 1 month after
Study 1.
Results: Study 1: (a) Roentgenographic stages of coxarthrosis. Disagree-
ment was most apparent among the three groups of almost normal,
prearthrosis and the initial stage. Moreover, several observers classiﬁed
some hips as “almost normal or prearthrosis”. Considering the power
of statistical analysis, we dealt with these two categories as one unit.
Consequently, the kappa statistics was calculated as 0.448 and the
strength of agreement was evaluated as Moderate. (b) Roentgenographic
indexes of acetabular dysplasia. The value of coefﬁcient of variation was
smallest in the acetabular angle and increased in the following order; the
AHQ, the acetabular roof obliquity, the CE angle, and the AAQ.
Study 2: The value of the kappa statistics was calculated as 0.600.
Conclusions: For the multi-center survey, clear description of the stages
of coxarthrosis and selection of appropriate indexes may be helpful for
collecting dependable results.
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Purpose: Trials in OA examining pain outcomes often allow use of escape
analgesia, which may minimize treatment (Tx) differences. Little is known
about the pattern of escape analgesia use & its relation to pain in
such trials. Using data from a null randomized cross-over trial of shoe
inserts (SIS) for pain Tx of OA where escape analgesia was permitted &
documented by daily diaries, we describe the pattern of analgesic use,
its correlation with pain scores & if there was a difference in escape
analgesic usage between Tx & placebo. Previous studies have not had
detailed information that would permit comprehensive evaluation of the
quantity of analgesia used & its relation to pain
Methods: During the SIS trial, subjects recorded daily pain medication
use via a diary which was collected at each study visit. All of the 90
randomized subjects who had at least 1 visit (maximum 4 visits) with
both a completed diary & WOMAC pain subscale (n = 77) were used in
the analysis. Analgesics, NSAIDS & COX-2 meds used 7-days prior to
study visit (to reﬂect the same recalled time period of the WOMAC pain
VAS subscale) were transformed to acetaminophen equivalencies (AEq).
AEq transformation was based on methods used by Allen (JAGS 51:534
2003). We evaluated the correlation between pain score & AEq use with
a Spearman rank test & tested the difference between Tx & placebo in
escape analgesia with a Wilcoxon paired signed rank test
Table 1: WOMAC Pain & medication usage (n = 77 Subjects)
WOMAC pain, % visits Treatment visits Placebo visits
past 7 days
(range 6–489)
taking meds # visits median MG/
day of AEq
# visits median MG/
day of AEq
<100 52% 32 46 30 164
100–199 54% 45 93 24 58
200–299 65% 34 223 62 429
300–399 77% 30 650 18 650
400–489 77% 6 1,433 7 929
Total 62% 147 325 141 371
Results: Table 1 highlights AEq use stratiﬁed by WOMAC Pain score &
visit type. The direct correlation between WOMAC pain & AEq for the Tx &
placebo visits was 0.25 (p = 0.03) & 0.26 (p = 0.03) respectively. Wilcoxon
paired signed ranked test indicated there was no signiﬁcant difference
in analgesic use between Tx & placebo (p = 0.59). Since Pain score &
analgesic use were not inversely related, analgesics did not reverse any
effect of treatment.
Conclusions: Pain score & analgesic use were modestly correlated, but
analgesic use did not differ between Tx & placebo therefore did not affect
the directionality or magnitude of the Tx effect.
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Purpose: There are marked racial/ethnic differences in the utilization of
total joint replacement (TJR) for osteoarthritis (OA). Racial differences
in patient preference may be an explanation for the observed variation
in utilization rates, but the factors that mediate the relationship between
patient race and preference for joint replacement (JR) have been under-
studied. Therefore, we sampled primary care patients who were clinical
candidates for JR to examine potential mediators of the relationship
between race and patient preference for TJR.
Methods: The sample consisted of 894 veterans (451 African-American
[AA], 443 white) 50 years of age or older who receive primary care in
two VA Medical Centers and had moderate to severe hip or knee OA
as indicated by WOMAC score >39. We used the previously validated
Hospital for Special Surgery Joint Replacement Expectations Survey
(JRES) to assess patients’ expectations for pain relief, functional im-
provement, and psychological well-being after surgery and a previously
published willingness question to assess patient preference. Structured
interviews were used to collect information on demographic, psychoso-
cial (health literacy level, social support, mental health well-being, pain
coping, religiosity, and risk preference), and patient knowledge regarding
JR. We a priori identiﬁed variables as covariates (age, income, edu-
cational level, WOMAC score and SF-12 mental status subscale) and
others as potential mediators (knowledge, JRES, social support and pain
coping). We performed bivariate analyses to examine the relationships
between race, patient preference, and potential mediators. Those factors
associated with both race and preference were analyzed using multi-
ple logistic regression modeling preference as a function of race and
the potential mediators, adjusted for patient covariates. Non-signiﬁcant
mediator variables (P> 0.05) were removed using backwards stepwise-
selection. Comparison of the adjusted race effect in this model to the
unadjusted race effects without the mediator variables were made to
assess whether these variables mediated the relationship between race
and patient preference. All models were adjusted for site of study.
Results: In this sample, AA patients were slightly younger (P< 0.001)
and reported lower educational level (P< 0.001); lower household income
(P< 0.001); and lower literacy level (P< 0.001). White patients reported
higher preference for JR (72% vs 60%, P< 0.001); were more likely to
have received a referral for surgery (32% vs 26%, P=0.05); and less likely
to have tried prayer to treat their chronic pain (56% vs 73%, P 0.001).
Compared to patients with high preference for surgery, those with low
preference had lower scores on social support scale (P< 0.001); pain
coping measure (P=0.04); and knee and hip JRES (P< 0.001 for both).
They also reported less understanding of JR and expected longer hospital
stay, more pain and difﬁculty walking after JR surgery, were less likely to
report having had a discussion with a doctor about surgery, and less likely
to have received a recommendation for surgery (P 0.005 for all).
AA to white unadjusted odds ratio (OR) for willingness to consider
surgery (preference) was 0.69 (95%CI = 0.51−0.93) and was unchanged
after adjusting for patient covariates. However, after the addition of the
statistically signiﬁcant potential mediators (patient knowledge, JRES and
social support), the OR became 0.88 and was no longer statistically
signiﬁcant (95%CI = 0.62−1.24).
Conclusions: In this sample, the relationship between patient race and
preference for JR is mediated by patient knowledge and expectations
regarding surgery and social support.
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Purpose: Diabetes can affect the musculoskeletal system in a variety of
ways. Hormone disturbances have been associated with early cartilage
